HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vitamin K deficiency bleeding after NICE guidance and withdrawal of Konakion Neonatal: British Paediatric Surveillance Unit study, 2006-2008.

AbstractOBJECTIVE:
To survey vitamin K deficiency bleeding (VKDB) and document vitamin K (VK) prophylaxis practice, and compare with findings predating withdrawal of Konakion Neonatal and guidance from the National Institute of Health and Clinical Excellence (NICE), both occurring in 2006.
DESIGN:
Two-year surveillance of VKDB (2006-2008) using British Paediatric Surveillance Unit methodology. Postal questionnaire to consultant-led maternity units.
SETTING:
UK and Irish Republic.
PATIENTS:
All newborns and infants under 6 months with suspected VKDB.
MAIN OUTCOME MEASURES:
VKDB incidence and predisposing factors, VK prophylaxis recommended/received.
RESULTS:
Eleven cases of VKDB were found: six (55%) babies received no VK prophylaxis, in five (45.5%) because parents withheld consent; three (27.5%) babies with late VKDB received intramuscular (IM) Konakion MM (two had biliary atresia, and one was delivered preterm); two (18%) babies received incomplete oral prophylaxis. Nine babies (82%) were breast fed. Three (27%) babies had liver disease; four (36%), including all those with liver disease, were jaundiced at presentation after 21 days. Four (36%) babies had intracranial haemorrhage, two probably suffering long-term morbidity. VK prophylaxis practice was defined in 236 (100%) units. All units recommended prophylaxis for every newborn: 169 (72%) IM, 19 (8%) oral, and 48 (20%) offered parental choice. All units that recommended IM prophylaxis used Konakion MM. Oral prophylaxis always involved multidose regimens for breastfed babies; 61 (91%) units used Konakion MM, and six (9%) used unlicensed products suitable for administration by parents.
CONCLUSIONS:
IM Konakion MM is efficacious, but parents withholding consent for recommended IM prophylaxis reduces effectiveness. Reappraisal of NICE guidance would be appropriate. Prolonged jaundice demands investigation. Late VKDB occasionally occurs after IM prophylaxis.
AuthorsAlison Busfield, Rebecca Samuel, Andrew McNinch, John H Tripp
JournalArchives of disease in childhood (Arch Dis Child) Vol. 98 Issue 1 Pg. 41-7 (Jan 2013) ISSN: 1468-2044 [Electronic] England
PMID23148314 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Vitamin K 1
Topics
  • Female
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Ireland (epidemiology)
  • Male
  • Practice Guidelines as Topic
  • Surveys and Questionnaires
  • United Kingdom (epidemiology)
  • Vitamin K 1 (administration & dosage)
  • Vitamin K Deficiency Bleeding (drug therapy, epidemiology)
  • Withholding Treatment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: